Survey on Acid Peptic Disorders: Analyzing Prescribing Pattern of PPIs
Journal Title: The Indian Practitioner - Year 2014, Vol 67, Issue 4
Abstract
Abstract: Acid peptic disorders (APDs) result from characteristic but overlapping pathogenic mechanisms that involve acid effects on diminished mucosal defense1. Proton pump inhibitors (PPIs) have become a mainstay in the management of acid peptic disorders (APDs). Objectives: This survey was aimed to determine the usage profile of different proton pump inhibitors and overall physicians’ opinion about the clinical experience with Adiza (Ilaprazole tablet 10 mg, marketed by Abbott India Limited) for the treatment of duodenal ulcer in adult. Methods: This survey was based on the clinical experience of 402 randomly selected physicians (gastroenterologists, gastrosurgeons, consulting physicians and general practitioners) on an aggregate patient basis in the management of acid-peptic disorders from different parts of India. A data report form (DRF) comprising of various questions was answered by these physicians. The responding physicians answered the DRF of patients who suffered from acid-peptic disorders and were eligible for PPI therapy. A minimum of 50 patients per physician were evaluated in this survey. Results: The commonly encountered acid peptic disorders in physicians’ clinical practice were dyspepsia and gastro oesophageal reflux disorder (GORD). 36.6% of physicians observed that GORD is frequently associated with the breakthrough symptoms especially during night time followed by duodenal ulcer (5%) and gastric ulcer (2.2%). 98.7% of physicians opined that ilaprazole provided a longer term acid suppression as compared to PPIs with shorter half-lives. 76.7% of physicians’ perceived excellent symptomatic relief, and 73.6% opined excellent tolerability in patients who were prescribed ilaprazole. Conclusion: This survey indicated that the main shortcomings observed by physicians with currently existing PPIs such as omeprazole, lansoprazole, pantoprazole, esomeprazole, rabeprazole were related to the ineffective nocturnal acid control and short plasma half-life of PPIs. Physicians opined that ilaprazole displays important advantages in their clinical practice, with regard to better probability of extending the inhibition of acid secretion over the nocturnal period. acid breakthrough (NAB).
Authors and Affiliations
N Chauhan
Keywords
Related Articles
- EP ID EP580966
- DOI -
- Views 57
- Downloads 0
Effective Management of H. pylori Infection in Peptic Ulcer Disease: An Indian Perspective
Background: Infection with Helicobacter Pylori (H.pylori) remains a major healthcare burden, with persistently high prevalence rates, especially in developing countries like India. H.pylori is the cause of most cases of...
Gestational Diabetes Mellitus: Screening Dilemmas
Gestational Diabetes Mellitus (GDM) is a common complication with increasing prevalence, to an extent due to lowered cut offs for diagnosis in addition to changing lifestyle. However there is a lot of variations in the s...
Study of lung function tests in patients of diabetes mellitus with chronic hyperglycaemia
The present study was carried out to compare the lung function tests in insulin dependent diabetes mellitus (IDDM) patients with chronic hyperglycaemia on insulin therapy for control of diabetes with healthy controls. Su...
Weight Loss in Healthy Neonates in First Three Days of Life
Aims: (1) To evaluate the weight loss in healthy breastfed neonates in first three days of their life. (2) To compare the weight loss between different periods of gestation and different birth weight. Purpose: This study...
‘Digital Uterine Evacuation – Revisited’ – For religious reasons as first line therapy for incomplete abortion
Objective: Digital uterine evacuation is very old and obsolete method for incomplete abortion. It still has a role especially in areas where women do not consent for surgical evacuation due to religious belief and at low...